Stage IIIC

1

Review clinical trials related to Stage IIIC. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Stereotactic Body Radiotherapy Boost Versus Simultaneous Integrated Boost to Pelvic Nodes Among Patients Receiving Radical Chemoradiation in Carcinoma Cervix

Cervical cancer is a significant cause of morbidity and mortality among women worldwide. Radiotherapy, in combination with chemotherapy or as a standalone treatment, is an effective treatment option for cervical cancer. However, traditional radiotherapy has its limitations, such as the potential for damage to surrounding healthy tissues. Stereotactic Body RadioTherapy (SBRT) is a newer radiotherapy technique that delivers high doses of radiation to the tumor with minimal damage to the surrounding tissues. This study aims to evaluate the safety of Stereotactic Body RadioTherapy to involved node in cervical cancer.

Participants needed: 150
Trial details
Age: 18-65Biological sex: FemaleType: InterventionalSponsor: All India Institute of Medical SciencesUpdated: May 29, 2026Locations: 3
Eligibility criteria

Patients with stage IIIC cervical cancer [+2]

Patients with stage I or stage II or stage IV disease. [+2]